Oxford University today joins a consortium led by the digital quantum computing company, SEEQC, to build and deliver a full-stack quantum computer for pharmaceutical drug development for Merck KGaA. The consortium has today been awarded a £6.85M grant by Innovate UK’s Industrial Strategy Challenge Fund (ISCF) to build a commercially scalable quantum computer designed to tackle prohibitively high costs within pharmaceutical drug development. The partnership will accelerate the use of quantum computing within pharmaceutical research to dramatically reduce the time required for drug development on a global scale.
Professor Charlotte Deane, who leads the Oxford Protein Informatics Group in the Department of Statistics and Professor Frank Von Delft, at the Centre for Medicines Discovery at the Nuffield Department of Medicine, will be leading from Oxford University. Find out more.
Professor Charlotte Deane elected Fellow of the Royal Society
Professor Charlotte Deane MBE, Professor of Structural Bioinformatics in Oxford’s Department of Statistics, has today been announced among the new Fellows of the Royal Society.
OpenBind releases first open dataset and AI model for drug discovery
The OpenBind consortium’s first release of experimental data marks a milestone in efforts to improve how artificial intelligence (AI) is used in drug discovery.
Oxford statisticians take part in PKU–Oxford conference on quantitative finance and data science
Researchers from the University of Oxford’s Department of Statistics were among those taking part in a joint conference with Peking University in April, bringing together academics working across quantitative finance, data science and related areas.